{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T05:12:30Z","timestamp":1772773950169,"version":"3.50.1"},"reference-count":191,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,9,14]],"date-time":"2014-09-14T00:00:00Z","timestamp":1410652800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Pathobiol Rep"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s40139-014-0053-z","type":"journal-article","created":{"date-parts":[[2014,9,13]],"date-time":"2014-09-13T10:48:03Z","timestamp":1410605283000},"page":"171-183","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["New Approaches for Studying Alcoholic Liver Disease"],"prefix":"10.1007","volume":"2","author":[{"given":"Jun","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Karin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidekazu","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana","family":"Kisseleva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,9,14]]},"reference":[{"key":"53_CR1","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Gao, B, Bataller, R (2011) Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 141:1572\u20131585. This review described the pathological process of alcoholic liver diseases from steatosis, alcoholic hepatitis, alcoholic fibrosis to the end stage hepatocellular carcinoma","DOI":"10.1053\/j.gastro.2011.09.002"},{"key":"53_CR2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","volume":"115","author":"R Bataller","year":"2005","unstructured":"Bataller R, Brenner DA (2005) Liver fibrosis. J Clin Invest 115:209\u2013218","journal-title":"J Clin Invest"},{"key":"53_CR3","first-page":"206","volume":"3","author":"AM Diehl","year":"1997","unstructured":"Diehl AM (1997) Alcoholic liver disease: natural history. Liver Transpl Surg 3:206\u2013211","journal-title":"Liver Transpl Surg"},{"key":"53_CR4","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/hep.20719","volume":"41","author":"T Adachi","year":"2005","unstructured":"Adachi T et al (2005) NAD(P)H oxidase plays a crucial role in PDGF-induced proliferation of hepatic stellate cells. Hepatology 41:1272\u20131281","journal-title":"Hepatology"},{"key":"53_CR5","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Gao B (2004) Therapeutic potential of interleukin-6 in preventing obesity- and alcohol-associated fatty liver transplant failure. Alcohol 34:59\u201365. This review discussed the protective effect of IL-6 administration on alcoholic\/steatotic liver isograft, and proposed IL-6 treatment to expand the liver donnor source for liver transplantation","DOI":"10.1016\/j.alcohol.2004.07.006"},{"key":"53_CR6","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/hep.510250120","volume":"25","author":"S Naveau","year":"1997","unstructured":"Naveau S et al (1997) Excess weight risk factor for alcoholic liver disease. Hepatology 25:108\u2013111","journal-title":"Hepatology"},{"key":"53_CR7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ng.488","volume":"42","author":"C Tian","year":"2010","unstructured":"Tian C, Stokowski RP, Kershenobich D, Ballinger DG, Hinds DA (2010) Variant in PNPLA3 is associated with alcoholic liver disease. Nat Genet 42:21\u201323","journal-title":"Nat Genet"},{"key":"53_CR8","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/hep.24017","volume":"53","author":"F Stickel","year":"2011","unstructured":"Stickel F et al (2011) Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians. Hepatology 53:86\u201395","journal-title":"Hepatology"},{"key":"53_CR9","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jhep.2011.01.028","volume":"55","author":"E Trepo","year":"2011","unstructured":"Trepo E et al (2011) Common polymorphism in the PNPLA3\/adiponutrin gene confers higher risk of cirrhosis and liver damage in alcoholic liver disease. J Hepatol 55:906\u2013912","journal-title":"J Hepatol"},{"key":"53_CR10","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1530-0277.2010.01399.x","volume":"35","author":"AM Miller","year":"2011","unstructured":"Miller AM, Horiguchi N, Jeong WI, Radaeva S, Gao B (2011) Molecular mechanisms of alcoholic liver disease: innate immunity and cytokines. Alcohol Clin Exp Res 35:787\u2013793","journal-title":"Alcohol Clin Exp Res"},{"key":"53_CR11","doi-asserted-by":"crossref","first-page":"29342","DOI":"10.1074\/jbc.M202411200","volume":"277","author":"M You","year":"2002","unstructured":"You M, Fischer M, Deeg MA, Crabb DW (2002) Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP). J Biol Chem 277:29342\u201329347","journal-title":"J Biol Chem"},{"key":"53_CR12","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/hep.23382","volume":"51","author":"F Esfandiari","year":"2010","unstructured":"Esfandiari F et al (2010) Epigenetic regulation of hepatic endoplasmic reticulum stress pathways in the ethanol-fed cystathionine beta synthase-deficient mouse. Hepatology 51:932\u2013941","journal-title":"Hepatology"},{"key":"53_CR13","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/hep.20309","volume":"40","author":"C Ji","year":"2004","unstructured":"Ji C, Deng Q, Kaplowitz N (2004) Role of TNF-alpha in ethanol-induced hyperhomocysteinemia and murine alcoholic liver injury. Hepatology 40:442\u2013451","journal-title":"Hepatology"},{"key":"53_CR14","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1172\/JCI37409","volume":"119","author":"Z Peng","year":"2009","unstructured":"Peng Z et al (2009) Adenosine signaling contributes to ethanol-induced fatty liver in mice. J Clin Invest 119:582\u2013594","journal-title":"J Clin Invest"},{"key":"53_CR15","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cmet.2007.12.007","volume":"7","author":"WI Jeong","year":"2008","unstructured":"Jeong WI et al (2008) Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver. Cell Metab 7:227\u2013235","journal-title":"Cell Metab"},{"key":"53_CR16","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1172\/JCI34827","volume":"118","author":"D Osei-Hyiaman","year":"2008","unstructured":"Osei-Hyiaman D et al (2008) Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice. J Clin Invest 118:3160\u20133169","journal-title":"J Clin Invest"},{"key":"53_CR17","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.4049\/jimmunol.181.5.3049","volume":"181","author":"XJ Zhao","year":"2008","unstructured":"Zhao XJ et al (2008) TRIF and IRF-3 binding to the TNF promoter results in macrophage TNF dysregulation and steatosis induced by chronic ethanol. J Immunol 181:3049\u20133056","journal-title":"J Immunol"},{"key":"53_CR18","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/hep.24059","volume":"53","author":"J Petrasek","year":"2011","unstructured":"Petrasek J et al (2011) Interferon regulatory factor 3 and type I interferons are protective in alcoholic liver injury in mice by way of crosstalk of parenchymal and myeloid cells. Hepatology 53:649\u2013660","journal-title":"Hepatology"},{"key":"53_CR19","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1053\/j.gastro.2005.02.065","volume":"128","author":"MR McMullen","year":"2005","unstructured":"McMullen MR et al (2005) Early growth response-1 transcription factor is essential for ethanol-induced fatty liver injury in mice. Gastroenterology 128:2066\u20132076","journal-title":"Gastroenterology"},{"key":"53_CR20","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Lafdil F, Miller AM, Ki SH, Gao B (2010) Th17 cells and their associated cytokines in liver diseases. Cell Mol Immunol 7:250\u2013254. This review described pathological role of Th17 by releasing cytokines, IL-17A and IL-22 during hepatic diseases. IL17A promotes biliary epithelial cells, hepatic stellate cells and kupffer cells secreting proinflammatory cytokines, while IL-22 protects hepatocytes from apoptosis","DOI":"10.1038\/cmi.2010.5"},{"key":"53_CR21","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1053\/j.gastro.2004.09.049","volume":"127","author":"M You","year":"2004","unstructured":"You M, Matsumoto M, Pacold CM, Cho WK, Crabb DW (2004) The role of AMP-activated protein kinase in the action of ethanol in the liver. Gastroenterology 127:1798\u20131808","journal-title":"Gastroenterology"},{"key":"53_CR22","doi-asserted-by":"crossref","first-page":"G892","DOI":"10.1152\/ajpgi.00575.2007","volume":"294","author":"M You","year":"2008","unstructured":"You M, Liang X, Ajmo JM, Ness GC (2008) Involvement of mammalian sirtuin 1 in the action of ethanol in the liver. Am J Physiol Gastrointest Liver Physiol 294:G892\u2013G898","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"53_CR23","doi-asserted-by":"crossref","first-page":"G364","DOI":"10.1152\/ajpgi.00456.2009","volume":"298","author":"Z Shen","year":"2010","unstructured":"Shen Z, Liang X, Rogers CQ, Rideout D, You M (2010) Involvement of adiponectin-SIRT1-AMPK signaling in the protective action of rosiglitazone against alcoholic fatty liver in mice. Am J Physiol Gastrointest Liver Physiol 298:G364\u2013G374","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"53_CR24","doi-asserted-by":"crossref","first-page":"850","DOI":"10.3181\/0902-MR-61","volume":"234","author":"M You","year":"2009","unstructured":"You M, Rogers CQ (2009) Adiponectin: a key adipokine in alcoholic fatty liver. Exp Biol Med 234:850\u2013859","journal-title":"Exp Biol Med"},{"key":"53_CR25","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Horiguchi N et al (2008) Cell type-dependent pro- and anti-inflammatory role of signal transducer and activator of transcription 3 in alcoholic liver injury. Gastroenterology 134:1148\u20131158. This report firstly described the dural role of IL-6 intracellular effector, STAT3, during pathogenesis of alcoholic liver diseases. Activation of STAT3 in hepatocytes suppresses expression of SREBP-1 and results in attenuation of steatosis induced by alcohol consumption. Meanwhile, activated STAT3 in hepatocytes promotes inflammation. In the Kupffer cells, activated STAT3 is mainly the effector of IL-10 to reduce pro-inflammatory cytokines secretion","DOI":"10.1053\/j.gastro.2008.01.016"},{"key":"53_CR26","doi-asserted-by":"crossref","first-page":"536","DOI":"10.7150\/ijbs.7.536","volume":"7","author":"H Wang","year":"2011","unstructured":"Wang H, Lafdil F, Kong X, Gao B (2011) Signal transducer and activator of transcription 3 in liver diseases: a novel therapeutic target. Int J Biol Sci 7:536\u2013550","journal-title":"Int J Biol Sci"},{"key":"53_CR27","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jhep.2012.01.029","volume":"57","author":"B Gao","year":"2012","unstructured":"Gao B, Wang H, Lafdil F, Feng D (2012) STAT proteins: key regulators of anti-viral responses, inflammation, and tumorigenesis in the liver. J Hepatol 57:430\u2013441","journal-title":"J Hepatol"},{"key":"53_CR28","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jhep.2006.05.009","volume":"45","author":"C Ji","year":"2006","unstructured":"Ji C, Chan C, Kaplowitz N (2006) Predominant role of sterol response element binding proteins (SREBP) lipogenic pathways in hepatic steatosis in the murine intragastric ethanol feeding model. J Hepatol 45:717\u2013724","journal-title":"J Hepatol"},{"key":"53_CR29","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1002\/hep.24256","volume":"53","author":"B Nath","year":"2011","unstructured":"Nath B et al (2011) Hepatocyte-specific hypoxia-inducible factor-1alpha is a determinant of lipid accumulation and liver injury in alcohol-induced steatosis in mice. Hepatology 53:1526\u20131537","journal-title":"Hepatology"},{"key":"53_CR30","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1053\/j.gastro.2007.01.053","volume":"132","author":"MT Pritchard","year":"2007","unstructured":"Pritchard MT et al (2007) Differential contributions of C3, C5, and decay-accelerating factor to ethanol-induced fatty liver in mice. Gastroenterology 132:1117\u20131126","journal-title":"Gastroenterology"},{"key":"53_CR31","doi-asserted-by":"crossref","unstructured":"Cohen JI, Roychowdhury S, McMullen MR, Stavitsky AB, Nagy LE (2010) Complement and alcoholic liver disease: role of C1q in the pathogenesis of ethanol-induced liver injury in mice. Gastroenterology 139:664\u2013674, 674 e661","DOI":"10.1053\/j.gastro.2010.04.041"},{"key":"53_CR32","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.abb.2008.11.004","volume":"482","author":"JP Kaiser","year":"2009","unstructured":"Kaiser JP et al (2009) PKCepsilon plays a causal role in acute ethanol-induced steatosis. Arch Biochem Biophys 482:104\u2013111","journal-title":"Arch Biochem Biophys"},{"key":"53_CR33","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1053\/j.gastro.2003.08.030","volume":"125","author":"SE McKim","year":"2003","unstructured":"McKim SE et al (2003) Inducible nitric oxide synthase is required in alcohol-induced liver injury: studies with knockout mice. Gastroenterology 125:1834\u20131844","journal-title":"Gastroenterology"},{"key":"53_CR34","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1053\/j.gastro.2011.12.044","volume":"142","author":"V Hernandez-Gea","year":"2012","unstructured":"Hernandez-Gea V et al (2012) Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues. Gastroenterology 142:938\u2013946","journal-title":"Gastroenterology"},{"key":"53_CR35","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.3748\/wjg.15.1178","volume":"15","author":"TM Donohue Jr","year":"2009","unstructured":"Donohue TM Jr (2009) Autophagy and ethanol-induced liver injury. World J Gastroenterol 15:1178\u20131185","journal-title":"World J Gastroenterol"},{"key":"53_CR36","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.bbrc.2010.09.127","volume":"402","author":"D Wu","year":"2010","unstructured":"Wu D, Wang X, Zhou R, Cederbaum A (2010) CYP2E1 enhances ethanol-induced lipid accumulation but impairs autophagy in HepG2 E47 cells. Biochem Biophys Res Commun 402:116\u2013122","journal-title":"Biochem Biophys Res Commun"},{"key":"53_CR37","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1101\/gad.1199904","volume":"18","author":"WX Zong","year":"2004","unstructured":"Zong WX, Ditsworth D, Bauer DE, Wang ZQ, Thompson CB (2004) Alkylating DNA damage stimulates a regulated form of necrotic cell death. Genes Dev 18:1272\u20131282","journal-title":"Genes Dev"},{"key":"53_CR38","doi-asserted-by":"crossref","first-page":"5887","DOI":"10.4049\/jimmunol.167.10.5887","volume":"167","author":"T Kawai","year":"2001","unstructured":"Kawai T et al (2001) Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J Immunol 167:5887\u20135894","journal-title":"J Immunol"},{"key":"53_CR39","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.smim.2006.12.004","volume":"19","author":"T Kawai","year":"2007","unstructured":"Kawai T, Akira S (2007) TLR signaling. Semin Immunol 19:24\u201332","journal-title":"Semin Immunol"},{"key":"53_CR40","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1053\/j.gastro.2012.09.008","volume":"143","author":"P Kubes","year":"2012","unstructured":"Kubes P, Mehal WZ (2012) Sterile inflammation in the liver. Gastroenterology 143:1158\u20131172","journal-title":"Gastroenterology"},{"key":"53_CR41","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1093\/emboj\/20.16.4337","volume":"20","author":"S Muller","year":"2001","unstructured":"Muller S et al (2001) New EMBO members\u2019 review: the double life of HMGB1 chromatin protein: architectural factor and extracellular signal. EMBO J 20:4337\u20134340","journal-title":"EMBO J"},{"key":"53_CR42","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.jhep.2010.07.004","volume":"53","author":"D Thabut","year":"2010","unstructured":"Thabut D, Shah V (2010) Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: new targets for the treatment of portal hypertension? J Hepatol 53:976\u2013980","journal-title":"J Hepatol"},{"key":"53_CR43","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1146\/annurev-nutr-072610-145138","volume":"32","author":"HJ Wang","year":"2012","unstructured":"Wang HJ, Gao B, Zakhari S, Nagy LE (2012) Inflammation in alcoholic liver disease. Annu Rev Nutr 32:343\u2013368","journal-title":"Annu Rev Nutr"},{"key":"53_CR44","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nri2586","volume":"9","author":"SL Gaffen","year":"2009","unstructured":"Gaffen SL (2009) Structure and signalling in the IL-17 receptor family. Nat Rev Immunol 9:556\u2013567","journal-title":"Nat Rev Immunol"},{"key":"53_CR45","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1165\/ajrcmb.26.6.4757","volume":"26","author":"CE Jones","year":"2002","unstructured":"Jones CE, Chan K (2002) Interleukin-17 stimulates the expression of interleukin-8, growth-related oncogene-alpha, and granulocyte-colony-stimulating factor by human airway epithelial cells. Am J Respir Cell Mol Biol 26:748\u2013753","journal-title":"Am J Respir Cell Mol Biol"},{"key":"53_CR46","doi-asserted-by":"crossref","first-page":"5504","DOI":"10.3748\/wjg.v18.i39.5504","volume":"18","author":"AD Dhanda","year":"2012","unstructured":"Dhanda AD, Lee RW, Collins PL, McCune CA (2012) Molecular targets in the treatment of alcoholic hepatitis. World J Gastroenterol 18:5504\u20135513","journal-title":"World J Gastroenterol"},{"key":"53_CR47","first-page":"92","volume":"2","author":"B Gao","year":"2005","unstructured":"Gao B (2005) Cytokines, STATs and liver disease. Cell Mol Immunol 2:92\u2013100","journal-title":"Cell Mol Immunol"},{"key":"53_CR48","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Ki SH et al (2010) Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3. Hepatology 52:1291\u20131300. This work described a new murine alcoholic liver disease model: chronic plus binge alcohol consumption. By utilizing this model, the authors demonstrated IL-22 treatment ameliorated alcohol induced steatosis and hepatitis via activation of hepatic STAT3 signaling","DOI":"10.1002\/hep.23837"},{"key":"53_CR49","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Yan AW et al (2011) Enteric dysbiosis associated with a mouse model of alcoholic liver disease. Hepatology 53:96\u2013105. This paper demonstrated the alcohol assumption could promote intestinal bacterial overgrowth and translocation. Such microflora changes might be induced by suppression of Reg3b and Reg3g expressions within small intestine","DOI":"10.1002\/hep.24018"},{"key":"53_CR50","doi-asserted-by":"crossref","first-page":"110","DOI":"10.4254\/wjh.v4.i4.110","volume":"4","author":"AW Yan","year":"2012","unstructured":"Yan AW, Schnabl B (2012) Bacterial translocation and changes in the intestinal microbiome associated with alcoholic liver disease. World J Hepatol 4:110\u2013118","journal-title":"World J Hepatol"},{"key":"53_CR51","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/hep.23009","volume":"50","author":"R Rao","year":"2009","unstructured":"Rao R (2009) Endotoxemia and gut barrier dysfunction in alcoholic liver disease. Hepatology 50:638\u2013644","journal-title":"Hepatology"},{"key":"53_CR52","doi-asserted-by":"crossref","first-page":"48S","DOI":"10.1111\/j.1530-0277.2000.tb04552.x","volume":"24","author":"M Fujimoto","year":"2000","unstructured":"Fujimoto M et al (2000) Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance. Alcohol Clin Exp Res 24:48S\u201354S","journal-title":"Alcohol Clin Exp Res"},{"key":"53_CR53","doi-asserted-by":"crossref","first-page":"172S","DOI":"10.1097\/01.alc.0000189278.30237.e9","volume":"29","author":"H Fukui","year":"2005","unstructured":"Fukui H (2005) Relation of endotoxin, endotoxin binding proteins and macrophages to severe alcoholic liver injury and multiple organ failure. Alcohol Clin Exp Res 29:172S\u2013179S","journal-title":"Alcohol Clin Exp Res"},{"key":"53_CR54","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/hep.22306","volume":"48","author":"E Seki","year":"2008","unstructured":"Seki E, Brenner DA (2008) Toll-like receptors and adaptor molecules in liver disease: update. Hepatology 48:322\u2013335","journal-title":"Hepatology"},{"key":"53_CR55","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/hep.23258","volume":"51","author":"RS O\u2019Shea","year":"2010","unstructured":"O\u2019Shea RS, Dasarathy S, McCullough AJ, Practice Guideline Committee of the American Association for the Study of Liver, D. & Practice Parameters Committee of the American College of Gastroenterology (2010) Alcoholic liver disease. Hepatology 51:307\u2013328","journal-title":"Hepatology"},{"key":"53_CR56","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1056\/NEJMra0805786","volume":"360","author":"MR Lucey","year":"2009","unstructured":"Lucey MR, Mathurin P, Morgan TR (2009) Alcoholic hepatitis. N Engl J Med 360:2758\u20132769","journal-title":"N Engl J Med"},{"key":"53_CR57","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","volume":"134","author":"SL Friedman","year":"2008","unstructured":"Friedman SL (2008) Mechanisms of hepatic fibrogenesis. Gastroenterology 134:1655\u20131669","journal-title":"Gastroenterology"},{"key":"53_CR58","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/nm1663","volume":"13","author":"E Seki","year":"2007","unstructured":"Seki E et al (2007) TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med 13:1324\u20131332","journal-title":"Nat Med"},{"key":"53_CR59","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Friedman SL, Roll FJ, Boyles J, Bissell DM (1985) Hepatic lipocytes: the principal collagen-producing cells of normal rat liver. Proc Natl Acad Sci USA 82:8681\u20138685. The first paper indicated that hepatic stellate cells are the major collagen deposition cells during liver fibrosis","DOI":"10.1073\/pnas.82.24.8681"},{"key":"53_CR60","doi-asserted-by":"crossref","first-page":"G516","DOI":"10.1152\/ajpgi.00537.2010","volume":"300","author":"B Gao","year":"2011","unstructured":"Gao B et al (2011) Innate immunity in alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol 300:G516\u2013G525","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"53_CR61","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0168-8278(00)00089-1","volume":"34","author":"S Natori","year":"2001","unstructured":"Natori S et al (2001) Hepatocyte apoptosis is a pathologic feature of human alcoholic hepatitis. J Hepatol 34:248\u2013253","journal-title":"J Hepatol"},{"key":"53_CR62","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.mam.2007.10.001","volume":"29","author":"T Mello","year":"2008","unstructured":"Mello T, Ceni E, Surrenti C, Galli A (2008) Alcohol induced hepatic fibrosis: role of acetaldehyde. Mol Aspects Med 29:17\u201321","journal-title":"Mol Aspects Med"},{"key":"53_CR63","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1189\/JLB.0309135","volume":"86","author":"B Gao","year":"2009","unstructured":"Gao B, Radaeva S, Park O (2009) Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases. J Leukoc Biol 86:513\u2013528","journal-title":"J Leukoc Biol"},{"key":"53_CR64","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1053\/j.gastro.2005.10.055","volume":"130","author":"S Radaeva","year":"2006","unstructured":"Radaeva S et al (2006) Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. Gastroenterology 130:435\u2013452","journal-title":"Gastroenterology"},{"key":"53_CR65","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1172\/JCI1018","volume":"102","author":"JP Iredale","year":"1998","unstructured":"Iredale JP et al (1998) Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest 102:538\u2013549","journal-title":"J Clin Invest"},{"key":"53_CR66","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Kisseleva T et al (2012) Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis. Proc Natl Acad Sci USA 109:9448\u20139453. This paper firstly observed the inactivation of hepatic stellate cells during liver fibrosis regression, rather than apoptosis","DOI":"10.1073\/pnas.1201840109"},{"key":"53_CR67","doi-asserted-by":"crossref","unstructured":"Troeger JS et al (2012) Deactivation of hepatic stellate cells during liver fibrosis resolution in mice. Gastroenterology 143:1073","DOI":"10.1053\/j.gastro.2012.06.036"},{"key":"53_CR68","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.tibtech.2003.09.011","volume":"21","author":"L Gilbertson","year":"2003","unstructured":"Gilbertson L (2003) Cre\u2013lox recombination: Cre-ative tools for plant biotechnology. Trends Biotechnol 21:550\u2013555","journal-title":"Trends Biotechnol"},{"key":"53_CR69","doi-asserted-by":"crossref","first-page":"4959","DOI":"10.1074\/jbc.M410078200","volume":"280","author":"H She","year":"2005","unstructured":"She H, Xiong S, Hazra S, Tsukamoto H (2005) Adipogenic transcriptional regulation of hepatic stellate cells. J Biol Chem 280:4959\u20134967","journal-title":"J Biol Chem"},{"key":"53_CR70","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1002\/hep.22193","volume":"47","author":"RG Wells","year":"2008","unstructured":"Wells RG (2008) The role of matrix stiffness in regulating cell behavior. Hepatology 47:1394\u20131400","journal-title":"Hepatology"},{"key":"53_CR71","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0945-053X(03)00017-9","volume":"22","author":"MD Gaca","year":"2003","unstructured":"Gaca MD et al (2003) Basement membrane-like matrix inhibits proliferation and collagen synthesis by activated rat hepatic stellate cells: evidence for matrix-dependent deactivation of stellate cells. Matrix Biol 22:229\u2013239","journal-title":"Matrix Biol"},{"key":"53_CR72","doi-asserted-by":"crossref","first-page":"190","DOI":"10.2302\/kjm.54.190","volume":"54","author":"H Tsukamoto","year":"2005","unstructured":"Tsukamoto H (2005) Fat paradox in liver disease. Keio J Med 54:190\u2013192","journal-title":"Keio J Med"},{"key":"53_CR73","doi-asserted-by":"crossref","unstructured":"\u2022 Tsukamoto H (2005) Adipogenic phenotype of hepatic stellate cells. Alcohol Clin Exp Res 29:132S\u2013133S . This review summarized the transcription factor codes (PPAR-gamma, C\/EBPs, SREBP-1c and LX-alpha) that specified the adipocyte fate of hepatic stellate cells which maintained its quiescent status","DOI":"10.1097\/01.alc.0000189279.92602.f0"},{"key":"53_CR74","first-page":"3811","volume":"50","author":"S Sell","year":"1990","unstructured":"Sell S (1990) Is there a liver stem cell? Cancer Res 50:3811\u20133815","journal-title":"Cancer Res"},{"key":"53_CR75","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1385\/SCR:1:3:253","volume":"1","author":"MR Alison","year":"2005","unstructured":"Alison MR (2005) Liver stem cells: implications for hepatocarcinogenesis. Stem Cell Rev 1:253\u2013260","journal-title":"Stem Cell Rev"},{"key":"53_CR76","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/j.1440-1746.2006.04485.x","volume":"21","author":"XZ Wu","year":"2006","unstructured":"Wu XZ, Chen D (2006) Origin of hepatocellular carcinoma: role of stem cells. J Gastroenterol Hepatol 21:1093\u20131098","journal-title":"J Gastroenterol Hepatol"},{"key":"53_CR77","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.2741\/e448","volume":"4","author":"Y Shen","year":"2012","unstructured":"Shen Y, Cao D (2012) Hepatocellular carcinoma stem cells: origins and roles in hepatocarcinogenesis and disease progression. Front Biosci 4:1157\u20131169","journal-title":"Front Biosci"},{"key":"53_CR78","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Naugler WE et al (2007) Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 317:121\u2013124. The paper discovered the differential expression of IL-6 between male and female mice, when they were under diethylnitrosamine (DEN) challenging. It explained the gender disparity in liver cancer","DOI":"10.1126\/science.1140485"},{"key":"53_CR79","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 He G et al (2013)Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling. Cell 155:384\u2013396. This report discovered the IL-6 signaling from HCC progenitor is required for its maligance and differentiation into cancer cells","DOI":"10.1016\/j.cell.2013.09.031"},{"key":"53_CR80","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1476-4598-10-150","volume":"10","author":"FM Gu","year":"2011","unstructured":"Gu FM et al (2011) IL-17 induces AKT-dependent IL-6\/JAK2\/STAT3 activation and tumor progression in hepatocellular carcinoma. Molecular cancer 10:150","journal-title":"Molecular cancer"},{"key":"53_CR81","doi-asserted-by":"crossref","first-page":"e21816","DOI":"10.1371\/journal.pone.0021816","volume":"6","author":"J Li","year":"2011","unstructured":"Li J et al (2011) Interleukin 17A promotes hepatocellular carcinoma metastasis via NF-kB induced matrix metalloproteinases 2 and 9 expression. PLoS One 6:e21816","journal-title":"PLoS One"},{"key":"53_CR82","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/hep.24486","volume":"54","author":"R Jiang","year":"2011","unstructured":"Jiang R et al (2011) Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3. Hepatology 54:900\u2013909","journal-title":"Hepatology"},{"key":"53_CR83","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 He G et al. (2010) Hepatocyte IKKbeta\/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation. Cancer Cell 17:286\u2013297. This report elucidated the role of IKK-beta in inhibiting JNK or STAT3 to eliminate progression of HCC progenitor differentiate into mature cancer","DOI":"10.1016\/j.ccr.2009.12.048"},{"key":"53_CR84","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nrc2734","volume":"9","author":"H Yu","year":"2009","unstructured":"Yu H, Pardoll D, Jove R (2009) STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 9:798\u2013809","journal-title":"Nat Rev Cancer"},{"key":"53_CR85","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/carcin\/bgi292","volume":"27","author":"JK Sicklick","year":"2006","unstructured":"Sicklick JK et al (2006) Dysregulation of the Hedgehog pathway in human hepatocarcinogenesis. Carcinogenesis 27:748\u2013757","journal-title":"Carcinogenesis"},{"key":"53_CR86","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Karin M (2009) NF-kappaB as a critical link between inflammation and cancer. Cold Spring Harb Perspect Biol 1:a000141. NF-kappaB is activated by pro-inflammatory cytokines IL-17 and TNFs from activated macrophages and lymphocytes. Downstream genes of NF-kappaB promote cancer cell proliferation and survival","DOI":"10.1101\/cshperspect.a000141"},{"key":"53_CR87","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Sakurai T et al (2008) Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis. Cancer Cell 14:156\u2013165. Carcinogenesis effect of Ikk-beta is mediated by IL-1\u03b1 releasing and ROS accumulation","DOI":"10.1016\/j.ccr.2008.06.016"},{"key":"53_CR88","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1053\/j.gastro.2011.12.001","volume":"142","author":"BD White","year":"2012","unstructured":"White BD, Chien AJ, Dawson DW (2012) Dysregulation of Wnt\/beta-catenin signaling in gastrointestinal cancers. Gastroenterology 142:219\u2013232","journal-title":"Gastroenterology"},{"key":"53_CR89","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1053\/j.gastro.2004.09.020","volume":"127","author":"TR Morgan","year":"2004","unstructured":"Morgan TR, Mandayam S, Jamal MM (2004) Alcohol and hepatocellular carcinoma. Gastroenterology 127:S87\u2013S96","journal-title":"Gastroenterology"},{"key":"53_CR90","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1055\/s-0029-1214377","volume":"29","author":"IH McKillop","year":"2009","unstructured":"McKillop IH, Schrum LW (2009) Role of alcohol in liver carcinogenesis. Semin Liver Dis 29:222\u2013232","journal-title":"Semin Liver Dis"},{"key":"53_CR91","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.alcohol.2012.08.004","volume":"46","author":"E Brandon-Warner","year":"2012","unstructured":"Brandon-Warner E, Schrum LW, Schmidt CM, McKillop IH (2012) Rodent models of alcoholic liver disease: of mice and men. Alcohol 46:715\u2013725","journal-title":"Alcohol"},{"key":"53_CR92","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1530-0277.2011.01660.x","volume":"36","author":"E Brandon-Warner","year":"2012","unstructured":"Brandon-Warner E, Walling TL, Schrum LW, McKillop IH (2012) Chronic ethanol feeding accelerates hepatocellular carcinoma progression in a sex-dependent manner in a mouse model of hepatocarcinogenesis. Alcohol Clin Exp Res 36:641\u2013653","journal-title":"Alcohol Clin Exp Res"},{"key":"53_CR93","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Machida K et al (2009) Toll-like receptor 4 mediates synergism between alcohol and HCV in hepatic oncogenesis involving stem cell marker Nanog. Proc Natl Acad Sci USA 106:1548\u20131553. The synergistical effect of HCV infection and alcohol consumption is mediated by TLR4 signaling. TLR4 expression is firstly elevated by HCV protein NS5A. Alcohol consumption permealizes gastrointestinal tract to facilitate bacterial translocation into liver and endotoxin released by intestinal bacterial induces TLR4 downstream gene Nanog expression","DOI":"10.1073\/pnas.0807390106"},{"key":"53_CR94","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Bertola A, Mathews S, Ki S, Wang H, Gao B (2013) Mouse chronic plus binge ethanol feeding model (the NIAAA model). Nat Protoc, in press. This paper described the method of chronic alcohol consumption and single high dose of alcohol binge, causing more severe steatosis and neutrophil infiltration than chronic alcohol feeding alone","DOI":"10.1038\/nprot.2013.032"},{"key":"53_CR95","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Ueno A et al (2012) Mouse intragastric infusion (iG) model. Nat Protoc 7:771\u2013781. This paper reported a novel alcohol feeding protocol by implanting gastrostomy catheter into gastrointestinal tract to create the alcoholic liver disease model. This ALD model is characterized by elevated alanine aminotranferase levels and severe hepatic steatosis","DOI":"10.1038\/nprot.2012.014"},{"issue":"Suppl","key":"53_CR96","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1111\/jgh.1998.13.s1.39","volume":"13","author":"RG Thurman","year":"1998","unstructured":"Thurman RG et al (1998) The role of gut-derived bacterial toxins and free radicals in alcohol-induced liver injury. J Gastroenterol Hepatol 13(Suppl):S39\u2013S50","journal-title":"J Gastroenterol Hepatol"},{"key":"53_CR97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-1119(02)00398-0","volume":"285","author":"T Kisseleva","year":"2002","unstructured":"Kisseleva T, Bhattacharya S, Braunstein J, Schindler CW (2002) Signaling through the JAK\/STAT pathway, recent advances and future challenges. Gene 285:1\u201324","journal-title":"Gene"},{"issue":"2125\u20132135","key":"53_CR98","first-page":"e2121","volume":"137","author":"F Lafdil","year":"2009","unstructured":"Lafdil F et al (2009) Myeloid STAT3 inhibits T cell-mediated hepatitis by regulating T helper 1 cytokine and interleukin-17 production. Gastroenterology 137(2125\u20132135):e2121\u2013e2122","journal-title":"Gastroenterology"},{"key":"53_CR99","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Meng F et al (2012) Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice. Gastroenterology 143:765\u2013776, e761\u2013763. In response to liver injury (hepatotoxicity and biliary obstruction), IL-17A expression is increased and IL-17A directly activates hepatic stellate cells by STAT3 signaling","DOI":"10.1053\/j.gastro.2012.05.049"},{"key":"53_CR100","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1042\/BST0341028","volume":"34","author":"PJ Murray","year":"2006","unstructured":"Murray PJ (2006) STAT3-mediated anti-inflammatory signalling. Biochem Soc Trans 34:1028\u20131031","journal-title":"Biochem Soc Trans"},{"key":"53_CR101","doi-asserted-by":"crossref","first-page":"7880","DOI":"10.4049\/jimmunol.177.11.7880","volume":"177","author":"KC Kasmi El","year":"2006","unstructured":"El Kasmi KC et al (2006) General nature of the STAT3-activated anti-inflammatory response. J Immunol 177:7880\u20137888","journal-title":"J Immunol"},{"key":"53_CR102","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1002\/hep.23430","volume":"51","author":"H Wang","year":"2010","unstructured":"Wang H et al (2010) Interplay of hepatic and myeloid signal transducer and activator of transcription 3 in facilitating liver regeneration via tempering innate immunity. Hepatology 51:1354\u20131362","journal-title":"Hepatology"},{"key":"53_CR103","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1002\/hep.23532","volume":"51","author":"N Horiguchi","year":"2010","unstructured":"Horiguchi N et al (2010) Dissociation between liver inflammation and hepatocellular damage induced by carbon tetrachloride in myeloid cell-specific signal transducer and activator of transcription 3 gene knockout mice. Hepatology 51:1724\u20131734","journal-title":"Hepatology"},{"key":"53_CR104","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1172\/JCI0215841","volume":"110","author":"F Hong","year":"2002","unstructured":"Hong F et al (2002) Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS. J Clin Invest 110:1503\u20131513","journal-title":"J Clin Invest"},{"key":"53_CR105","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.immuni.2007.07.023","volume":"27","author":"LA Zenewicz","year":"2007","unstructured":"Zenewicz LA et al (2007) Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity 27:647\u2013659","journal-title":"Immunity"},{"key":"53_CR106","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/hep.23322","volume":"51","author":"DC Kroy","year":"2010","unstructured":"Kroy DC et al (2010) Lack of interleukin-6\/glycoprotein 130\/signal transducers and activators of transcription-3 signaling in hepatocytes predisposes to liver steatosis and injury in mice. Hepatology 51:463\u2013473","journal-title":"Hepatology"},{"key":"53_CR107","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1002\/hep.21837","volume":"46","author":"R Sakamori","year":"2007","unstructured":"Sakamori R et al (2007) Signal transducer and activator of transcription 3 signaling within hepatocytes attenuates systemic inflammatory response and lethality in septic mice. Hepatology 46:1564\u20131573","journal-title":"Hepatology"},{"key":"53_CR108","doi-asserted-by":"crossref","unstructured":"Weng H, Li H, Dooley S (2011) Inflammation does not always kill hepatocytes during liver damage. Hepatology 54:366; author reply 367.","DOI":"10.1002\/hep.24166"},{"key":"53_CR109","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.bbrc.2011.02.105","volume":"406","author":"M Shigekawa","year":"2011","unstructured":"Shigekawa M et al (2011) Involvement of STAT3-regulated hepatic soluble factors in attenuation of stellate cell activity and liver fibrogenesis in mice. Biochem Biophys Res Commun 406:614\u2013620","journal-title":"Biochem Biophys Res Commun"},{"key":"53_CR110","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.2353\/ajpath.2010.090469","volume":"176","author":"W Plum","year":"2010","unstructured":"Plum W et al (2010) Lack of glycoprotein 130\/signal transducer and activator of transcription 3-mediated signaling in hepatocytes enhances chronic liver injury and fibrosis progression in a model of sclerosing cholangitis. Am J Pathol 176:2236\u20132246","journal-title":"Am J Pathol"},{"key":"53_CR111","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.4049\/jimmunol.1203013","volume":"191","author":"Z Tan","year":"2013","unstructured":"Tan Z et al (2013) IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation. J Immunol 191:1835\u20131844","journal-title":"J Immunol"},{"key":"53_CR112","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/hep.25744","volume":"56","author":"X Kong","year":"2012","unstructured":"Kong X et al (2012) Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice. Hepatology 56:1150\u20131159","journal-title":"Hepatology"},{"key":"53_CR113","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.ajpath.2011.05.005","volume":"179","author":"H Wang","year":"2011","unstructured":"Wang H et al (2011) Hepatoprotective versus oncogenic functions of STAT3 in liver tumorigenesis. Am J Pathol 179:714\u2013724","journal-title":"Am J Pathol"},{"key":"53_CR114","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/hep.24339","volume":"54","author":"O Park","year":"2011","unstructured":"Park O et al (2011) In vivo consequences of liver-specific interleukin-22 expression in mice: implications for human liver disease progression. Hepatology 54:252\u2013261","journal-title":"Hepatology"},{"key":"53_CR115","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1084\/jem.20070820","volume":"205","author":"KJ Riehle","year":"2008","unstructured":"Riehle KJ et al (2008) Regulation of liver regeneration and hepatocarcinogenesis by suppressor of cytokine signaling 3. J Exp Med 205:91\u2013103","journal-title":"J Exp Med"},{"key":"53_CR116","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.ccr.2011.03.023","volume":"19","author":"EA Bard-Chapeau","year":"2011","unstructured":"Bard-Chapeau EA et al (2011) Ptpn11\/Shp2 acts as a tumor suppressor in hepatocellular carcinogenesis. Cancer Cell 19:629\u2013639","journal-title":"Cancer Cell"},{"key":"53_CR117","first-page":"58","volume":"1","author":"C Johnson","year":"2012","unstructured":"Johnson C et al (2012) Interleukin-6 and its receptor, key players in hepatobiliary inflammation and cancer. Transl Gastrointest Cancer 1:58\u201370","journal-title":"Transl Gastrointest Cancer"},{"key":"53_CR118","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cmet.2014.05.001","volume":"20","author":"A Umemura","year":"2014","unstructured":"Umemura A et al (2014) Liver damage, inflammation, and enhanced tumorigenesis after persistent mTORC1 inhibition. Cell Metab 20:133\u2013144","journal-title":"Cell Metab"},{"key":"53_CR119","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/0888-7543(88)90152-8","volume":"3","author":"AM Bowcock","year":"1988","unstructured":"Bowcock AM et al (1988) The human \u201cinterferon-beta 2\/hepatocyte stimulating factor\/interleukin-6\u201d gene: dNA polymorphism studies and localization to chromosome 7p21. Genomics 3:8\u201316","journal-title":"Genomics"},{"key":"53_CR120","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.3748\/wjg.v19.i16.2449","volume":"19","author":"L Giannitrapani","year":"2013","unstructured":"Giannitrapani L, Soresi M, Balasus D, Licata A, Montalto G (2013) Genetic association of interleukin-6 polymorphism (\u2212174 G\/C) with chronic liver diseases and hepatocellular carcinoma. World J Gastroenterol 19:2449\u20132455","journal-title":"World J Gastroenterol"},{"key":"53_CR121","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1172\/JCI2629","volume":"102","author":"D Fishman","year":"1998","unstructured":"Fishman D et al (1998) The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102:1369\u20131376","journal-title":"J Clin Invest"},{"key":"53_CR122","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/carcin\/bgn286","volume":"30","author":"S Ognjanovic","year":"2009","unstructured":"Ognjanovic S, Yuan JM, Chaptman AK, Fan Y, Yu MC (2009) Genetic polymorphisms in the cytokine genes and risk of hepatocellular carcinoma in low-risk non-Asians of USA. Carcinogenesis 30:758\u2013762","journal-title":"Carcinogenesis"},{"key":"53_CR123","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.humimm.2010.06.006","volume":"71","author":"E Falleti","year":"2010","unstructured":"Falleti E et al (2010) Genetic polymorphisms of interleukin-6 modulate fibrosis progression in mild chronic hepatitis C. Hum Immunol 71:999\u20131004","journal-title":"Hum Immunol"},{"key":"53_CR124","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1159\/000260057","volume":"77","author":"E Falleti","year":"2009","unstructured":"Falleti E et al (2009) Interleukin-6 polymorphisms and gender: relationship with the occurrence of hepatocellular carcinoma in patients with end-stage liver disease. Oncology 77:304\u2013313","journal-title":"Oncology"},{"key":"53_CR125","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/ni.1668","volume":"10","author":"T Cupedo","year":"2009","unstructured":"Cupedo T et al (2009) Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC\u00a0+\u00a0CD127\u00a0+\u00a0natural killer-like cells. Nat Immunol 10:66\u201374","journal-title":"Nat Immunol"},{"key":"53_CR126","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nri2522","volume":"9","author":"E Vivier","year":"2009","unstructured":"Vivier E, Spits H, Cupedo T (2009) Interleukin-22-producing innate immune cells: new players in mucosal immunity and tissue repair? Nat Rev Immunol 9:229\u2013234","journal-title":"Nat Rev Immunol"},{"key":"53_CR127","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nm1710","volume":"14","author":"SJ Aujla","year":"2008","unstructured":"Aujla SJ et al (2008) IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med 14:275\u2013281","journal-title":"Nat Med"},{"key":"53_CR128","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1084\/jem.20072713","volume":"206","author":"H Takatori","year":"2009","unstructured":"Takatori H et al (2009) Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J Exp Med 206:35\u201341","journal-title":"J Exp Med"},{"key":"53_CR129","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.4049\/jimmunol.0903907","volume":"186","author":"K Wolk","year":"2011","unstructured":"Wolk K et al (2011) Deficiency of IL-22 contributes to a chronic inflammatory disease: pathogenetic mechanisms in acne inversa. J Immunol 186:1228\u20131239","journal-title":"J Immunol"},{"key":"53_CR130","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1074\/jbc.M007837200","volume":"276","author":"SV Kotenko","year":"2001","unstructured":"Kotenko SV et al (2001) Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10R beta) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes. J Biol Chem 276:2725\u20132732","journal-title":"J Biol Chem"},{"key":"53_CR131","doi-asserted-by":"crossref","first-page":"33676","DOI":"10.1074\/jbc.M204204200","volume":"277","author":"D Lejeune","year":"2002","unstructured":"Lejeune D et al (2002) Interleukin-22 (IL-22) activates the JAK\/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10. J Biol Chem 277:33676\u201333682","journal-title":"J Biol Chem"},{"key":"53_CR132","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/hep.20184","volume":"39","author":"S Radaeva","year":"2004","unstructured":"Radaeva S, Sun R, Pan HN, Hong F, Gao B (2004) Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology 39:1332\u20131342","journal-title":"Hepatology"},{"key":"53_CR133","doi-asserted-by":"crossref","unstructured":"Feng D et al (2012) Interleukin-22 promotes proliferation of liver stem\/progenitor cells in mice and patients with chronic hepatitis B virus infection. Gastroenterology 143:188\u2013198 e187","DOI":"10.1053\/j.gastro.2012.03.044"},{"key":"53_CR134","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.immuni.2006.06.002","volume":"24","author":"CT Weaver","year":"2006","unstructured":"Weaver CT, Harrington LE, Mangan PR, Gavrieli M, Murphy KM (2006) Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24:677\u2013688","journal-title":"Immunity"},{"key":"53_CR135","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nm1551","volume":"13","author":"L Steinman","year":"2007","unstructured":"Steinman L (2007) A brief history of T(H)17, the first major revision in the T(H)1\/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med 13:139\u2013145","journal-title":"Nat Med"},{"key":"53_CR136","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","volume":"126","author":"II Ivanov","year":"2006","unstructured":"Ivanov II et al (2006) The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17\u00a0+\u00a0T helper cells. Cell 126:1121\u20131133","journal-title":"Cell"},{"key":"53_CR137","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.immuni.2007.11.016","volume":"28","author":"XO Yang","year":"2008","unstructured":"Yang XO et al (2008) T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity 28:29\u201339","journal-title":"Immunity"},{"key":"53_CR138","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","volume":"441","author":"E Bettelli","year":"2006","unstructured":"Bettelli E et al (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441:235\u2013238","journal-title":"Nature"},{"key":"53_CR139","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature04754","volume":"441","author":"PR Mangan","year":"2006","unstructured":"Mangan PR et al (2006) Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441:231\u2013234","journal-title":"Nature"},{"key":"53_CR140","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.immuni.2004.08.018","volume":"21","author":"JK Kolls","year":"2004","unstructured":"Kolls JK, Linden A (2004) Interleukin-17 family members and inflammation. Immunity 21:467\u2013476","journal-title":"Immunity"},{"key":"53_CR141","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.immuni.2011.02.012","volume":"34","author":"Y Iwakura","year":"2011","unstructured":"Iwakura Y, Ishigame H, Saijo S, Nakae S (2011) Functional specialization of interleukin-17 family members. Immunity 34:149\u2013162","journal-title":"Immunity"},{"key":"53_CR142","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/1074-7613(95)90070-5","volume":"3","author":"Z Yao","year":"1995","unstructured":"Yao Z et al (1995) Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity 3:811\u2013821","journal-title":"Immunity"},{"key":"53_CR143","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.4049\/jimmunol.169.4.1683","volume":"169","author":"A Andoh","year":"2002","unstructured":"Andoh A et al (2002) IL-17 selectively down-regulates TNF-alpha-induced RANTES gene expression in human colonic subepithelial myofibroblasts. J Immunol 169:1683\u20131687","journal-title":"J Immunol"},{"key":"53_CR144","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1006\/bbrc.1999.1156","volume":"262","author":"SV Subramaniam","year":"1999","unstructured":"Subramaniam SV, Cooper RS, Adunyah SE (1999) Evidence for the involvement of JAK\/STAT pathway in the signaling mechanism of interleukin-17. Biochem Biophys Res Commun 262:14\u201319","journal-title":"Biochem Biophys Res Commun"},{"key":"53_CR145","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrd3794","volume":"11","author":"P Miossec","year":"2012","unstructured":"Miossec P, Kolls JK (2012) Targeting IL-17 and TH17 cells in chronic inflammation. Nat Rev Drug Discovery 11:763\u2013776","journal-title":"Nat Rev Drug Discovery"},{"key":"53_CR146","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1084\/jem.194.4.519","volume":"194","author":"P Ye","year":"2001","unstructured":"Ye P et al (2001) Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 194:519\u2013527","journal-title":"J Exp Med"},{"key":"53_CR147","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cyto.2007.11.013","volume":"41","author":"F Shen","year":"2008","unstructured":"Shen F, Gaffen SL (2008) Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy. Cytokine 41:92\u2013104","journal-title":"Cytokine"},{"key":"53_CR148","doi-asserted-by":"crossref","first-page":"7297","DOI":"10.4049\/jimmunol.0902446","volume":"183","author":"SM Faust","year":"2009","unstructured":"Faust SM et al (2009) Role of T cell TGFbeta signaling and IL-17 in allograft acceptance and fibrosis associated with chronic rejection. J Immunol 183:7297\u20137306","journal-title":"J Immunol"},{"key":"53_CR149","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1084\/jem.20092121","volume":"207","author":"MS Wilson","year":"2010","unstructured":"Wilson MS et al (2010) Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent. J Exp Med 207:535\u2013552","journal-title":"J Exp Med"},{"key":"53_CR150","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jhep.2004.03.008","volume":"41","author":"MS Longhi","year":"2004","unstructured":"Longhi MS et al (2004) Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease. J Hepatol 41:31\u201337","journal-title":"J Hepatol"},{"key":"53_CR151","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/hep.22680","volume":"49","author":"A Lemmers","year":"2009","unstructured":"Lemmers A et al (2009) The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology 49:646\u2013657","journal-title":"Hepatology"},{"key":"53_CR152","doi-asserted-by":"crossref","unstructured":"Affo S et al (2012) Transcriptome analysis identifies TNF superfamily receptors as potential therapeutic targets in alcoholic hepatitis. Gut 62:452\u2013460","DOI":"10.1136\/gutjnl-2011-301146"},{"key":"53_CR153","first-page":"1156","volume":"24","author":"J Maltby","year":"1996","unstructured":"Maltby J, Wright S, Bird G, Sheron N (1996) Chemokine levels in human liver homogenates: associations between GRO alpha and histopathological evidence of alcoholic hepatitis. Hepatology 24:1156\u20131160","journal-title":"Hepatology"},{"key":"53_CR154","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1053\/j.gastro.2009.01.056","volume":"136","author":"M Dominguez","year":"2009","unstructured":"Dominguez M et al (2009) Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis. Gastroenterology 136:1639\u20131650","journal-title":"Gastroenterology"},{"key":"53_CR155","doi-asserted-by":"crossref","first-page":"345803","DOI":"10.1155\/2011\/345803","volume":"2011","author":"L Hammerich","year":"2011","unstructured":"Hammerich L, Heymann F, Tacke F (2011) Role of IL-17 and Th17 cells in liver diseases. Clin Dev Immunol 2011:345803","journal-title":"Clin Dev Immunol"},{"key":"53_CR156","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20041257","volume":"201","author":"CL Langrish","year":"2005","unstructured":"Langrish CL et al (2005) IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201:233\u2013240","journal-title":"J Exp Med"},{"key":"53_CR157","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1084\/jem.20030896","volume":"198","author":"CA Murphy","year":"2003","unstructured":"Murphy CA et al (2003) Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 198:1951\u20131957","journal-title":"J Exp Med"},{"key":"53_CR158","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S1074-7613(00)00070-4","volume":"13","author":"B Oppmann","year":"2000","unstructured":"Oppmann B et al (2000) Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13:715\u2013725","journal-title":"Immunity"},{"key":"53_CR159","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nature01355","volume":"421","author":"DJ Cua","year":"2003","unstructured":"Cua DJ et al (2003) Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421:744\u2013748","journal-title":"Nature"},{"key":"53_CR160","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S1074-7613(01)00243-6","volume":"15","author":"MM Fort","year":"2001","unstructured":"Fort MM et al (2001) IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 15:985\u2013995","journal-title":"Immunity"},{"key":"53_CR161","doi-asserted-by":"crossref","first-page":"443","DOI":"10.4049\/jimmunol.169.1.443","volume":"169","author":"SD Hurst","year":"2002","unstructured":"Hurst SD et al (2002) New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25. J Immunol 169:443\u2013453","journal-title":"J Immunol"},{"key":"53_CR162","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/ni1497","volume":"8","author":"NJ Wilson","year":"2007","unstructured":"Wilson NJ et al (2007) Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 8:950\u2013957","journal-title":"Nat Immunol"},{"key":"53_CR163","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s10875-009-9328-2","volume":"30","author":"J Ge","year":"2010","unstructured":"Ge J et al (2010) Implication of Th17 and Th1 cells in patients with chronic active hepatitis B. J Clin Immunol 30:60\u201367","journal-title":"J Clin Immunol"},{"key":"53_CR164","doi-asserted-by":"crossref","unstructured":"Mann J et al (2010) MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis. Gastroenterology 138:705\u2013714, 714 e701\u2013704","DOI":"10.1053\/j.gastro.2009.10.002"},{"key":"53_CR165","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1872-034X.2011.00804.x","volume":"41","author":"H Tsukamoto","year":"2011","unstructured":"Tsukamoto H, Zhu NL, Asahina K, Mann DA, Mann J (2011) Epigenetic cell fate regulation of hepatic stellate cells. Hepatol Res 41:675\u2013682","journal-title":"Hepatol Res"},{"key":"53_CR166","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1038\/nmeth.1371","volume":"6","author":"S Pepke","year":"2009","unstructured":"Pepke S, Wold B, Mortazavi A (2009) Computation for ChIP-seq and RNA-seq studies. Nat Methods 6:S22\u2013S32","journal-title":"Nat Methods"},{"key":"53_CR167","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nrg2641","volume":"10","author":"PJ Park","year":"2009","unstructured":"Park PJ (2009) ChIP-seq: advantages and challenges of a maturing technology. Nat Rev Genet 10:669\u2013680","journal-title":"Nat Rev Genet"},{"key":"53_CR168","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrg2206","volume":"9","author":"S Henikoff","year":"2008","unstructured":"Henikoff S (2008) Nucleosome destabilization in the epigenetic regulation of gene expression. Nat Rev Genet 9:15\u201326","journal-title":"Nat Rev Genet"},{"key":"53_CR169","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Heinz S, Glass CK (2012) Roles of lineage-determining transcription factors in establishing open chromatin: lessons from high-throughput studies. Curr Top Microbiol Immunol 356:1\u201315. The methods to study epigenetic changes in different cell types are symmarized in this paper","DOI":"10.1007\/82_2011_142"},{"key":"53_CR170","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1146\/annurev.nutr.28.061807.155438","volume":"28","author":"JM Mato","year":"2008","unstructured":"Mato JM, Martinez-Chantar ML, Lu SC (2008) Methionine metabolism and liver disease. Annu Rev Nutr 28:273\u2013293","journal-title":"Annu Rev Nutr"},{"key":"53_CR171","doi-asserted-by":"crossref","unstructured":"\u2022 Tsukamoto H, Zhu NL, Wang J, Asahina K, Machida K (2012) Morphogens and hepatic stellate cell fate regulation in chronic liver disease. J Gastroenterol Hepatol 27(Suppl 2):94\u201398. Important findings on epigenetic regulation of alcohol-activated myofibroblasts are described in this paper","DOI":"10.1111\/j.1440-1746.2011.07022.x"},{"key":"53_CR172","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Yang MD et al (2012) Rosmarinic acid and baicalin epigenetically derepress peroxisomal proliferator-activated receptor gamma in hepatic stellate cells for their antifibrotic effect. Hepatology 55:1271\u20131281. This paper demonstrates novel pathway of regulation of HSCs","DOI":"10.1002\/hep.24792"},{"key":"53_CR173","doi-asserted-by":"crossref","first-page":"11392","DOI":"10.1074\/jbc.M310284200","volume":"279","author":"S Hazra","year":"2004","unstructured":"Hazra S et al (2004) Peroxisome proliferator-activated receptor gamma induces a phenotypic switch from activated to quiescent hepatic stellate cells. J Biol Chem 279:11392\u201311401","journal-title":"J Biol Chem"},{"key":"53_CR174","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/j.1582-4934.2005.tb00497.x","volume":"9","author":"R Jaster","year":"2005","unstructured":"Jaster R et al (2005) Peroxisome proliferator-activated receptor gamma overexpression inhibits pro-fibrogenic activities of immortalised rat pancreatic stellate cells. J Cell Mol Med 9:670\u2013682","journal-title":"J Cell Mol Med"},{"key":"53_CR175","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281\u2013297","journal-title":"Cell"},{"key":"53_CR176","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/jcmm.12223","volume":"18","author":"K McDaniel","year":"2014","unstructured":"McDaniel K et al (2014) The functional role of microRNAs in alcoholic liver injury. J Cell Mol Med 18:197\u2013207","journal-title":"J Cell Mol Med"},{"key":"53_CR177","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1074\/jbc.M110.145870","volume":"286","author":"S Bala","year":"2011","unstructured":"Bala S et al (2011) Up-regulation of microRNA-155 in macrophages contributes to increased tumor necrosis factor alpha (TNF{alpha}) production via increased mRNA half-life in alcoholic liver disease. J Biol Chem 286:1436\u20131444","journal-title":"J Biol Chem"},{"key":"53_CR178","doi-asserted-by":"crossref","first-page":"5633","DOI":"10.3748\/wjg.15.5633","volume":"15","author":"S Bala","year":"2009","unstructured":"Bala S, Marcos M, Szabo G (2009) Emerging role of microRNAs in liver diseases. World J Gastroenterol 15:5633\u20135640","journal-title":"World J Gastroenterol"},{"key":"53_CR179","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1530-0277.2007.00584.x","volume":"32","author":"Y Tang","year":"2008","unstructured":"Tang Y et al (2008) Effect of alcohol on miR-212 expression in intestinal epithelial cells and its potential role in alcoholic liver disease. Alcohol Clin Exp Res 32:355\u2013364","journal-title":"Alcohol Clin Exp Res"},{"key":"53_CR180","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1111\/j.1530-0277.2009.01007.x","volume":"33","author":"A Dolganiuc","year":"2009","unstructured":"Dolganiuc A et al (2009) MicroRNA expression profile in Lieber\u2013DeCarli diet-induced alcoholic and methionine choline deficient diet-induced nonalcoholic steatohepatitis models in mice. Alcohol Clin Exp Res 33:1704\u20131710","journal-title":"Alcohol Clin Exp Res"},{"key":"53_CR181","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/mp.56.2.127","volume":"56","author":"DR Brigstock","year":"2003","unstructured":"Brigstock DR et al (2003) Proposal for a unified CCN nomenclature. Mol Pathol 56:127\u2013128","journal-title":"Mol Pathol"},{"key":"53_CR182","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.2741\/4067","volume":"17","author":"G Huang","year":"2012","unstructured":"Huang G, Brigstock DR (2012) Regulation of hepatic stellate cells by connective tissue growth factor. Front Biosci (Landmark Ed) 17:2495\u20132507","journal-title":"Front Biosci (Landmark Ed)"},{"key":"53_CR183","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/hep.26768","volume":"59","author":"L Chen","year":"2014","unstructured":"Chen L et al (2014) Epigenetic regulation of connective tissue growth factor by MicroRNA-214 delivery in exosomes from mouse or human hepatic stellate cells. Hepatology 59:1118\u20131129","journal-title":"Hepatology"},{"key":"53_CR184","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/hep.20798","volume":"42","author":"G Svegliati-Baroni","year":"2005","unstructured":"Svegliati-Baroni G et al (2005) Early response of alpha2(I) collagen to acetaldehyde in human hepatic stellate cells is TGF-beta independent. Hepatology 42:343\u2013352","journal-title":"Hepatology"},{"key":"53_CR185","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.ajpath.2014.01.020","volume":"184","author":"K Reyes-Gordillo","year":"2014","unstructured":"Reyes-Gordillo K et al (2014) Mechanisms of action of acetaldehyde in the up-regulation of the human alpha2(I) collagen gene in hepatic stellate cells: key roles of Ski, SMAD3, SMAD4, and SMAD7. Am J Pathol 184:1458\u20131467","journal-title":"Am J Pathol"},{"key":"53_CR186","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1096\/fj.13-241646","volume":"28","author":"M Perez-Aso","year":"2014","unstructured":"Perez-Aso M, Fernandez P, Mediero A, Chan ES, Cronstein BN (2014) Adenosine 2A receptor promotes collagen production by human fibroblasts via pathways involving cyclic AMP and AKT but independent of Smad2\/3. FASEB J 28:802\u2013812","journal-title":"FASEB J"},{"key":"53_CR187","doi-asserted-by":"crossref","first-page":"R58","DOI":"10.1186\/ar4229","volume":"15","author":"ES Chan","year":"2013","unstructured":"Chan ES et al (2013) Adenosine A(2A) receptors promote collagen production by a Fli1- and CTGF-mediated mechanism. Arthritis Res Ther 15:R58","journal-title":"Arthritis Res Ther"},{"key":"53_CR188","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1080\/15257770802146403","volume":"27","author":"Z Peng","year":"2008","unstructured":"Peng Z et al (2008) Ecto-5\u2032-nucleotidase (CD73)-mediated extracellular adenosine production plays a critical role in hepatic fibrosis. Nucleosides Nucleotides Nucleic Acids 27:821\u2013824","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"53_CR189","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1096\/fj.07-100685","volume":"22","author":"Z Peng","year":"2008","unstructured":"Peng Z et al (2008) Ecto-5\u2032-nucleotidase (CD73)-mediated extracellular adenosine production plays a critical role in hepatic fibrosis. FASEB J 22:2263\u20132272","journal-title":"FASEB J"},{"key":"53_CR190","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1124\/mol.107.038760","volume":"72","author":"J Che","year":"2007","unstructured":"Che J, Chan ES, Cronstein BN (2007) Adenosine A2A receptor occupancy stimulates collagen expression by hepatic stellate cells via pathways involving protein kinase A, Src, and extracellular signal-regulated kinases 1\/2 signaling cascade or p38 mitogen-activated protein kinase signaling pathway. Mol Pharmacol 72:1626\u20131636","journal-title":"Mol Pharmacol"},{"key":"53_CR191","doi-asserted-by":"crossref","first-page":"e92482","DOI":"10.1371\/journal.pone.0092482","volume":"9","author":"H Wang","year":"2014","unstructured":"Wang H et al (2014) Caffeine inhibits the activation of hepatic stellate cells induced by acetaldehyde via adenosine A2A receptor mediated by the cAMP\/PKA\/SRC\/ERK1\/2\/P38 MAPK signal pathway. PLoS One 9:e92482","journal-title":"PLoS One"}],"container-title":["Current Pathobiology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40139-014-0053-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40139-014-0053-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40139-014-0053-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,17]],"date-time":"2022-04-17T00:08:38Z","timestamp":1650154118000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40139-014-0053-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,14]]},"references-count":191,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["53"],"URL":"https:\/\/doi.org\/10.1007\/s40139-014-0053-z","relation":{},"ISSN":["2167-485X"],"issn-type":[{"value":"2167-485X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,14]]}}}